M.K. Srinivasu

497 total citations
19 papers, 443 citations indexed

About

M.K. Srinivasu is a scholar working on Spectroscopy, Analytical Chemistry and Pharmacology. According to data from OpenAlex, M.K. Srinivasu has authored 19 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Spectroscopy, 11 papers in Analytical Chemistry and 6 papers in Pharmacology. Recurrent topics in M.K. Srinivasu's work include Analytical Chemistry and Chromatography (11 papers), Analytical Methods in Pharmaceuticals (11 papers) and Inflammatory mediators and NSAID effects (3 papers). M.K. Srinivasu is often cited by papers focused on Analytical Chemistry and Chromatography (11 papers), Analytical Methods in Pharmaceuticals (11 papers) and Inflammatory mediators and NSAID effects (3 papers). M.K. Srinivasu collaborates with scholars based in India and United States. M.K. Srinivasu's co-authors include G. Om Reddy, B. Mallikarjuna Rao, K. B. Chandrasekhar, Pramod Kumar, Pramod Kumar, Aminul Islam, Aloka Srinivasan, Arpita Chakraborty, K. Praveen Kumar and P. Madhavan and has published in prestigious journals such as Journal of Pharmaceutical and Biomedical Analysis, Chromatographia and International Journal of Livestock Research.

In The Last Decade

M.K. Srinivasu

19 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.K. Srinivasu India 14 189 178 112 77 58 19 443
Silvana A. Calafatti Brazil 11 169 0.9× 197 1.1× 98 0.9× 29 0.4× 59 1.0× 26 410
Mohammad Kashif India 12 179 0.9× 104 0.6× 104 0.9× 39 0.5× 45 0.8× 28 371
Nájla Mohamad Kassab Brazil 11 157 0.8× 119 0.7× 170 1.5× 76 1.0× 91 1.6× 33 457
Abdel-Khalek Mm Egypt 14 290 1.5× 171 1.0× 154 1.4× 85 1.1× 68 1.2× 49 539
Mukthinuthalapati Mathrusri Annapurna India 11 346 1.8× 221 1.2× 148 1.3× 48 0.6× 84 1.4× 141 611
P. Radhakrishnanand India 14 196 1.0× 155 0.9× 72 0.6× 42 0.5× 80 1.4× 60 435
Safaa Toubar Egypt 12 242 1.3× 167 0.9× 115 1.0× 42 0.5× 67 1.2× 45 483
Mohamed M. Salim Egypt 13 217 1.1× 149 0.8× 96 0.9× 27 0.4× 101 1.7× 40 481
A. Naidu India 12 156 0.8× 107 0.6× 104 0.9× 168 2.2× 71 1.2× 57 435
Paulo Renato de Oliveira Brazil 16 253 1.3× 168 0.9× 151 1.3× 75 1.0× 107 1.8× 61 690

Countries citing papers authored by M.K. Srinivasu

Since Specialization
Citations

This map shows the geographic impact of M.K. Srinivasu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.K. Srinivasu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.K. Srinivasu more than expected).

Fields of papers citing papers by M.K. Srinivasu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.K. Srinivasu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.K. Srinivasu. The network helps show where M.K. Srinivasu may publish in the future.

Co-authorship network of co-authors of M.K. Srinivasu

This figure shows the co-authorship network connecting the top 25 collaborators of M.K. Srinivasu. A scholar is included among the top collaborators of M.K. Srinivasu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.K. Srinivasu. M.K. Srinivasu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Kumar, Ramesh, et al.. (2012). Development of a RP-LC method for a diastereomeric drug valganciclovir hydrochloride by enhanced approach. Journal of Pharmaceutical and Biomedical Analysis. 70. 101–110. 14 indexed citations
3.
Srinivasu, M.K., et al.. (2009). Development and validation of a stability indicating LC method for the assay and related substances determination of Exemestane, an aromatase inhibitor. Journal of Pharmaceutical and Biomedical Analysis. 50(5). 746–752. 8 indexed citations
4.
Rao, B. Mallikarjuna, Arpita Chakraborty, M.K. Srinivasu, et al.. (2006). A stability-indicating HPLC assay method for docetaxel. Journal of Pharmaceutical and Biomedical Analysis. 41(2). 676–681. 69 indexed citations
5.
Rao, B. Mallikarjuna, et al.. (2006). Development and validation of a specific stability indicating high performance liquid chromatographic method for rizatriptan benzoate. Journal of Pharmaceutical and Biomedical Analysis. 41(4). 1146–1151. 42 indexed citations
6.
Badireddy, Madhusudana Rao, et al.. (2006). A Validated Chiral LC Method for the Determination of Enantiomeric Purity of Pemetrexed Disodium on an Amylose-Based Chiral Stationary Phase. Chromatographia. 65(3-4). 249–252. 4 indexed citations
7.
Rao, B. Mallikarjuna, et al.. (2006). A Rapid Stability-Indicating LC Method for Ziprasidone Hydrochloride. Chromatographia. 65(3-4). 191–196. 14 indexed citations
8.
Srinivasu, M.K., et al.. (2005). A validated chiral LC method for the enantiomeric separation of Zolmitriptan key intermediate, ZTR-5. Journal of Pharmaceutical and Biomedical Analysis. 39(3-4). 796–800. 8 indexed citations
9.
Rao, B. Mallikarjuna, et al.. (2005). A validated stability indicating ion-pair RP-LC method for zoledronic acid. Journal of Pharmaceutical and Biomedical Analysis. 39(3-4). 781–790. 28 indexed citations
10.
Rao, B. Mallikarjuna, et al.. (2005). A stability indicating LC method for Rivastigmine hydrogen tartrate. Journal of Pharmaceutical and Biomedical Analysis. 37(1). 57–63. 36 indexed citations
11.
Rao, B. Mallikarjuna, et al.. (2005). A stability indicating LC method for zolmitriptan. Journal of Pharmaceutical and Biomedical Analysis. 39(3-4). 503–509. 29 indexed citations
12.
Srinivasu, M.K., et al.. (2005). A validated chiral liquid chromatographic method for the enantiomeric separation of Rivastigmine hydrogen tartarate, a cholinesterase inhibitor. Journal of Pharmaceutical and Biomedical Analysis. 38(2). 320–325. 16 indexed citations
13.
Rao, B. Mallikarjuna, et al.. (2004). A validated chiral LC method for the enantioselective analysis of Levetiracetam and its enantiomer R-α-ethyl-2-oxo-pyrrolidine acetamide on amylose-based stationary phase. Journal of Pharmaceutical and Biomedical Analysis. 35(5). 1017–1026. 28 indexed citations
14.
Srinivasu, M.K., et al.. (2004). A validated chiral LC method for the determination of Zolmitriptan and its potential impurities. Journal of Pharmaceutical and Biomedical Analysis. 37(3). 453–460. 24 indexed citations
15.
Srinivasu, M.K., et al.. (2002). Determination of celecoxib, a COX-2 inhibitor, in pharmaceutical dosage forms by MEKC. Journal of Pharmaceutical and Biomedical Analysis. 28(3-4). 493–500. 23 indexed citations
16.
Srinivasu, M.K., et al.. (2002). Determination of lovastatin and simvastatin in pharmaceutical dosage forms by MEKC. Journal of Pharmaceutical and Biomedical Analysis. 29(4). 715–721. 50 indexed citations
17.
Srinivasu, M.K., et al.. (2001). LC separation of ortho and meta isomers of celecoxib in bulk and formulations using a chiral column. Journal of Pharmaceutical and Biomedical Analysis. 25(1). 21–30. 13 indexed citations
18.
Geetha, S., et al.. (2001). LC determination and purity evaluation of nefazodone HCl in bulk drug and pharmaceutical formulations. Journal of Pharmaceutical and Biomedical Analysis. 26(4). 629–636. 5 indexed citations
19.
Srinivasu, M.K., et al.. (2000). A validated LC method for the quantitative determination of celecoxib in pharmaceutical dosage forms and purity evaluation in bulk drugs. Journal of Pharmaceutical and Biomedical Analysis. 22(6). 949–956. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026